Healthy Minds With Dr. Jeffrey Borenstein

New Psychiatric Medications (Part Two)

New approaches to psychosis and schizophrenia treat symptoms without the side effects of traditional dopamine blockers; the potential for psychedelics to normalize brain function in depression within a psychotherapy framework; possible psychiatric use of GLP-1 medication to manage side effects and symptoms. Guest: John Krystal, MD., Chair, Department of Psychiatry, Yale School of Medicine.

More Episodes

Treatment of Psychosis in Teens and Young Adults

Symptom education for early intervention, and the benefits of a team approach with peer support.

Watch Now

Growing Brain Cells in The Lab

Pioneering work turns stem cells into brain cells in cultures to potentially treat disorders.

Watch Now

Autism (Part Two)

Prioritizing early intervention and education plans to give autistic children more opportunity.

Watch Now